MarketWatch

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX(R) (collagenase clostridium histolyticum)

MALVERN, Pa., Nov. 20, 2024 /CNW/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment ...
ABC News

Penis-Straightening Drug Xiaflex May Provide Relief for Peyronie's

Pfizer's new drug for claw hand may be used by men with bent phallus. Feb. 5, 2010— -- A new drug for claw hand, a condition that causes bent fingers, may serve double-duty as a ...
Morningstar

Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association

MALVERN, Pa., March 12, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or ...
abc27

Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)

MALVERN, Pa., Feb. 17, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its new branded television commercial, Steve's Journey. The campaign, featuring a real Dupuytren's ...
Medscape

Penile Treatment Shows Promise in Phase 3 Trials

SAN DIEGO, California — Collagenase Clostridium histolyticum (CCH) can significantly reduce the symptoms of Peyronie's disease, according to results from 2 phase 3 clinical trials. "From both a ...